New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 25, 2013
10:01 EDTWAGE, TEVA, TIVO, TWX, VIAB, VET, LCI, SUBCY, SAPMY, STRZA, NFLX, NGL, KYTH, MYL, HASI, ACT, DISH, DISCA, DTV, DIS, FOXAOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 21st Century Fox (FOXA) initiated with an Outperform at FBR Capital... Actavis (ACT) initiated with a Buy at Citigroup.... DISH (DISH) initiated with an Underperform at FBR Capital... DirecTV (DTV) initiated with a Market Perform at FBR Capital... Discovery (DISCA) initiated with an Outperform at FBR Capital... Disney (DIS) initiated with an Outperform at FBR Capital... Hannon Armstrong (HASI) initiated with a Sector Perform at RBC Capital... Kythera (KYTH) initiated with a Buy at BofA/Merrill... Mylan (MYL) initiated with a Neutral at Citigroup... NGL Energy Partners (NGL) initiated with an Outperform at Raymond James... Netflix (NFLX) initiated with a Market Perform at FBR Capital... Starz (STRZA) initiated with a Market Perform at FBR Capital... Teva (TEVA) initiated with a Buy at Citigroup... TiVo (TIVO) initiated with a Market Perform at FBR Capital... Time Warner (TWX) initiated with an Outperform at FBR Capital... Vermilion Energy (VET) initiated with a Neutral at Goldman... Viacom (VIAB) initiated with an Outperform at FBR Capital... Lannett (LCI) initiated with a Buy at BofA/Merrill... Subsea 7 (SUBCY) initiated with a Buy at Canaccord... Saipem (SAPMY) initiated with a Hold at Canaccord... WageWorks (WAGE) initiated with a Buy at SunTrust.
News For FOXA;ACT;DISH;DISCA;DTV;DIS;HASI;MYL;KYTH;NGL;NFLX;STRZA;TEVA;TIVO;TWX;VIAB;VET;LCI;SUBCY;SAPMY;WAGE From The Last 14 Days
Check below for free stories on FOXA;ACT;DISH;DISCA;DTV;DIS;HASI;MYL;KYTH;NGL;NFLX;STRZA;TEVA;TIVO;TWX;VIAB;VET;LCI;SUBCY;SAPMY;WAGE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
August 21, 2014
07:18 EDTTIVOTiVo volatility elevated into Q2 and outlook
TiVo September call option implied volatility is at 35, October is at 29, November is at 28; compared to its 26-week average of 31 according to Track Data, suggesting large near term price movement into the expected release of Q2 after the market close on August 26.
06:00 EDTTWXStocks with implied volatility below IV index mean; TWX WAG
Subscribe for More Information
August 20, 2014
17:32 EDTNGLNGL Energy Partners files to sell $300M of common units
12:59 EDTNFLXNetflix volatility at low end of historic range
Subscribe for More Information
11:44 EDTMYLMylan completes second bidding round for GSK prescription portfolio, WSJ says
Mylan (MYL), TPG Capital, Advent International, KKR (KKR), Warburg Pincus and a few Indian prescription manufacturers have completed the second round of bidding for GlaxoSmith Kline's (GSK) portfolio of mature medications, according to The Wall Street Journal, citing people familiar with the sales process. GSK noted that it aims to sell a portfolio of drug brands in the U.S. and EU with yearly sales of approximately $1.66B. Reference Link
11:35 EDTLCILannett expects to launch Estradiol tablets within the next several months
Lannett Company announced that it has agreed to purchase ANDAs for Estradiol Tablets, USP, 0.5 mg, 1 mg and 2 mg, and Selegiline Hydrochloride Capsules 5 mg, upon the completion of a successful technical transfer. The company did not disclose the name of the seller nor the financial terms of the transaction. Lannett expects to launch Estradiol Tablets within the next several months and Selegiline Hydrochloride Capsules sometime thereafter. According to IMS, for the full year 2013 total sales of Estradiol Tablets, USP, 0.5 mg, 1 mg and 2 mg, and Selegiline Hydrochloride Capsules 5 mg at Average Wholesale Price were approximately $31M and $8.5M, respectively. The reference listed drug manufacturer for Estradiol Tablets is Barr Laboratories; Selegiline Hydrochloride Capsules 5 mg is the generic equivalent of Somerset Pharmaceuticals, Inc.’s Eldepryl. “We are pleased to add Estradiol Tablets and Selegiline Hydrochloride Capsules to our offering,” said Arthur Bedrosian, president and chief executive officer of Lannett. “The acquisition of these two important medications further expands and diversifies our product portfolio and complements our internal research and development efforts.”
11:33 EDTMYLMylan into second round of bidding for GSK drug portfolio, WSJ reports
Subscribe for More Information
10:08 EDTLCILannett does not expect study to significantly impact Digoxin sales
Subscribe for More Information
09:36 EDTNFLXActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL FOLD TSLA TWTR WHX FB TM NFLX X EOG
07:56 EDTLCILannett digoxen use in clinics unlikely to change, says Canaccord
Canaccord said the use of Lannett's digoxen drug was only prescribed to critically ill Afib patients so the mortality risk cited in a retrospective study by Turakhia is not surprising. Given the risk of thrombotic events from Afib progression far outweighing the mortality risk the firm sees little change to clinical practice. Shares of Lannett are Buy rated with a $55 price target.
06:13 EDTNFLXNetflix signs paid peering deal with Time Warner Cable, Gigaom reports
Netflix (NFLX) has signed a direct interconnection deal with Time Warner Cable (TWC) that would provide Netflix with direct access and faster streams, reports Gigaom. Time Warner Cable confirmed that the deal happened in June and the implementation has been rolling out this month. Reference Link
August 19, 2014
16:00 EDTNFLXOptions Update; August 19, 2014eBay
iPath S&P 500 VIX Short-Term Futures down 28c to 27.52. Option volume leaders: AAPL C HD PBR GILD AA NFLX TWTR TSLA EBAY according to Track Data.
12:26 EDTLCILannett downgraded to Hold from Buy at Craig-Hallum
Subscribe for More Information
11:44 EDTMYLMylan launches generic Precedex Injection
Subscribe for More Information
11:18 EDTACTDepomed announces favorable ruling in Gralise case
Subscribe for More Information
10:32 EDTACTDepomed higher after favorable ruling in Gralise case
Subscribe for More Information
09:47 EDTLCILannett could see decreased digoxin sales, says Craig-Hallum
Subscribe for More Information
08:27 EDTNFLXNetflix international opportunity larger than most realize, says MKM Partners
Subscribe for More Information
07:26 EDTACTActavis confirms positive results from RECLAIM pivotal Phase III studies
Subscribe for More Information
05:11 EDTTEVAGamida Cell announces investment, option agreement with Novartis
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use